Ilaria Lucca

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


58 publications

2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2009 | 2008 |
 
Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria.
Lucca I., Hofbauer S.L., Haitel A., Susani M., Shariat S.F., Klatte T., De Martino M., 2019/07. Oncology letters, 18 (1) pp. 57-62. Peer-reviewed.
Double Positive CD4<sup>+</sup>CD8<sup>+</sup> T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization.
Bohner P., Chevalier M.F., Cesson V., Rodrigues-Dias S.C., Dartiguenave F., Burruni R., Tawadros T., Valerio M., Lucca I., Nardelli-Haefliger D. et al., 2019. Frontiers in immunology, 10 p. 622. Peer-reviewed.
 
A urinary microRNA (miR) signature for diagnosis of bladder cancer.
Hofbauer S.L., de Martino M., Lucca I., Haitel A., Susani M., Shariat S.F., Klatte T., 2018/12. Urologic oncology, 36 (12) pp. 531.e1-531.e8. Peer-reviewed.
 
Chirurgie ambulatoire en urologie : il est temps d’en parler [Ambulatory surgery in urology]
Haverdings H., Vola F., Altwegg G., Chollet M., Jichlinski P., Lucca I., 2018/11/28. Revue medicale suisse, 14 (629) pp. 2164-2166. Peer-reviewed.
 
Réhabilitation améliorée après chirurgie urologique majeure : quel rôle pour le médecin généraliste ? [Improved rehabilitation after major urological surgery : what role for the general practitioner ?]
Martel P., Crettenand F., M'baya O., Cerantola Y., Jichlinski P., Lucca I., 2018/11/28. Revue medicale suisse, 14 (629) pp. 2150-2153. Peer-reviewed.
 
Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy.
Chevalier M.F., Schneider A.K., Cesson V., Dartiguenave F., Lucca I., Jichlinski P., Nardelli-Haefliger D., Derré L., 2018/11. European urology, 74 (5) pp. 540-544. Peer-reviewed.
 
Intramuscular Immunization Induces Antigen-specific Antibodies in Urine.
Derré L., Lucca I., Cesson V., Valerio M., Cerantola Y., Burruni R., Fritschi U., Gharbi D., Bobst M., Legris A.S. et al., 2018/09/12. European urology focus. Peer-reviewed.
 
Ablation du cancer primaire dans les néoplasies urologiques oligométastatiques : évidence ou vœux pieux ? [Local treatment in oligometastatic urological malignancies : evidence of wishful thinking ?]
Valerio M., Cerantola Y., Lucca I., Berthold D., Jichlinski P., 2017/11/29. Revue medicale suisse, 13 (585) pp. 2083-2086. Peer-reviewed.
Immunothérapie : une révolution dans la prise en charge du cancer de la vessie ? [Immunotherapy : a revolution in the management of urothelial bladder cancer ?]
Adam S.M., Derré L., Jichlinski P., Lucca I., 2017/11/29. Revue medicale suisse, 13 (585) pp. 2074-2078. Peer-reviewed.
 
Carcinome urothélial de la vessie et des voies urinaires hautes
Julita Loïc, Jichlinski Patrice, Lucca Ilaria, 2017/08/30. Forum Médical Suisse ‒ Swiss Medical Forum, 17 (35). Peer-reviewed.
 
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer.
Soria F., Lucca I., Moschini M., Mathieu R., Rouprêt M., Karakiewicz P.I., Briganti A., Rink M., Gust K.M., Hassler M.R. et al., 2017/06. Urologic oncology, 35 (6) pp. 356-362. Peer-reviewed.
 
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
Derré L., Cesson V., Lucca I., Cerantola Y., Valerio M., Fritschi U., Vlamopoulos Y., Burruni R., Legris A.S., Dartiguenave F. et al., 2017/02/01. Clinical cancer research, 23 (3) pp. 717-725. Peer-reviewed.
 
Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study.
Mathieu R., Lucca I., Vartolomei M.D., Mbeutcha A., Klatte T., Seitz C., Karakiewicz P.I., Fajkovic H., Sun M., Lotan Y. et al., 2017/02. BJU international, 119 (2) pp. 234-238. Peer-reviewed.
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
Vartolomei M.D., Mathieu R., Margulis V., Karam J.A., Rouprêt M., Lucca I., Mbeutcha A., Seitz C., Karakiewicz P.I., Fajkovic H. et al., 2017/01. World journal of urology, 35 (1) pp. 121-130. Peer-reviewed.
 
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
Mbeutcha A., Shariat S.F., Rieken M., Rink M., Xylinas E., Seitz C., Lucca I., Mathieu R., Rouprêt M., Briganti A. et al., 2016/11. Urologic oncology, 34 (11) pp. 483.e17-483.e24. Peer-reviewed.
 
Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
de Martino M., Taus C., Lucca I., Hofbauer S.L., Haitel A., Shariat S.F., Klatte T., 2016/10. Molecular carcinogenesis, 55 (10) pp. 1458-1466. Peer-reviewed.
 
Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Fajkovic H., Shariat S.F., Klatte T., Vartolomei M.D., Lucca I., Mbeutcha A., Rouprêt M., Briganti A., Karakiewicz P.I., Margulis V. et al., 2016/10. World journal of urology, 34 (10) pp. 1411-1419. Peer-reviewed.
 
Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
Lucca I., Hofbauer S.L., Leitner C.V., de Martino M., Özsoy M., Susani M., Shariat S.F., Klatte T., 2016/09. Urology, 95 pp. 132-138. Peer-reviewed.
 
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent.
Mbeutcha A., Lucca I., Margulis V., Karam J.A., Wood C.G., de Martino M., Mathieu R., Haitel A., Xylinas E., Kluth L. et al., 2016/08. World journal of urology, 34 (8) pp. 1155-1161. Peer-reviewed.
 
The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder.
Mathieu R., Lucca I., Rouprêt M., Briganti A., Shariat S.F., 2016/08. Nature reviews. Urology, 13 (8) pp. 471-479. Peer-reviewed.
 
Dynamic Prognostication Using Conditional Recurrence and Progression Estimates for Patients with Nonmuscle Invasive Bladder Cancer.
Leitner C.V., Ederer I.A., de Martino M., Hofbauer S.L., Lucca I., Mbeutcha A., Mathieu R., Haitel A., Susani M., Shariat S.F. et al., 2016/07. The Journal of urology, 196 (1) pp. 46-51. Peer-reviewed.
 
Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
Lucca I., Shariat S.F., 2016/07. European urology, 70 (1) pp. 205-206. Peer-reviewed.
 
Serum Adiponectin Predicts Cancer-specific Survival of Patients with Renal Cell Carcinoma.
de Martino M., Leitner C.V., Hofbauer S.L., Lucca I., Haitel A., Shariat S.F., Klatte T., 2016/06. European urology focus, 2 (2) pp. 197-203. Peer-reviewed.
 
Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter.
Seisen T., Nison L., Remzi M., Klatte T., Mathieu R., Lucca I., Bozzini G., Capitanio U., Novara G., Cussenot O. et al., 2016/05. The Journal of urology, 195 (5) pp. 1354-1361. Peer-reviewed.
 
Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy.
Fajkovic H., Mathieu R., Lucca I., Hiess M., Hübner N., Al Hussein Al Awamlh B., Lee R., Briganti A., Karakiewicz P., Lotan Y. et al., 2016/05. Urologic oncology, 34 (5) pp. 233.e1-6. Peer-reviewed.
 
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis.
Lucca I., Jichlinski P., Shariat S.F., Rouprêt M., Rieken M., Kluth L.A., Rink M., Mathieu R., Mbeutcha A., Maj-Hes A. et al., 2016/04. European urology focus, 2 (1) pp. 79-85. Peer-reviewed.
 
Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer.
Mbeutcha A., Lucca I., Mathieu R., Lotan Y., Shariat S.F., 2016. Urologic Clinics of North America, 43 (1) pp. 47-62. Peer-reviewed.
 
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study.
Mathieu R., Klatte T., Lucca I., Mbeutcha A., Seitz C., Karakiewicz P.I., Fajkovic H., Sun M., Lotan Y., Scherr D.S. et al., 2016. Bju International, 118 (2) pp. 243-249. Peer-reviewed.
 
Gender differences in incidence and outcomes of urothelial and kidney cancer.
Lucca I., Klatte T., Fajkovic H., de Martino M., Shariat S.F., 2015/12..
 
Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M., Lucca I., Mbeutcha A., Wiener H.G., Haitel A., Susani M., Shariat S.F., Klatte T., 2015/10. European urology, 68 (4) pp. 552-554. Peer-reviewed.
 
Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC).
de Martino M., Leitner C.V., Seemann C., Hofbauer S.L., Lucca I., Haitel A., Shariat S.F., Klatte T., 2015/03. BJU international, 115 (3) pp. 397-404. Peer-reviewed.
 
Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
Lucca I., Rouprêt M., Kluth L., Rink M., Tilki D., Fajkovic H., Kassouf W., Hofbauer S.L., de Martino M., Karakiewicz P.I. et al., 2015. Bju International, 115 (5) pp. 722-727. Peer-reviewed.
 
Aurora A Kinase as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M., Shariat S.F., Hofbauer S.L., Lucca I., Taus C., Wiener H.G., Haitel A., Susani M., Klatte T., 2015/01. World journal of urology, 33 (1) pp. 105-110. Peer-reviewed.
 
Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma.
Lucca I., de Martino M., Hofbauer S.L., Zamani N., Shariat S.F., Klatte T., 2015. World Journal of Urology, 33 (12) pp. 2045-2052. Peer-reviewed.
 
Diagnosis and Management of Upper Tract Urothelial Carcinoma.
Lucca I., Leow J.J., Shariat S.F., Chang S.L., 2015. Hematology/oncology Clinics of North America, 29 (2) pp. 271-288. Peer-reviewed.
 
Histopathology and prognosis of de novo bladder tumors following solid organ transplantation.
Ederer I.A., Lucca I., Hofbauer S.L., Haidinger M., Haitel A., Susani M., Shariat S.F., Klatte T., 2015. World Journal of Urology, 33 (12) pp. 2087-2093. Peer-reviewed.
 
Inégalité des sexes face au cancer en urologie [Gender disparities in urologic cancers].
Lucca I., Valerio M., Jichlinski P., Cerantola Y., 2015. Revue Médicale Suisse, 11 (497) pp. 2276-8, 2280.
 
Kidney-sparing surgery for upper tract urothelial cancer.
Lucca I., Klatte T., Rouprêt M., Shariat S.F., 2015. Current Opinion in Urology, 25 (2) pp. 100-104. Peer-reviewed.
 
Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy.
Mathieu R., Shariat S.F., Seitz C., Karakiewicz P.I., Fajkovic H., Sun M., Lotan Y., Scherr D.S., Tewari A., Montorsi F. et al., 2015. World Journal of Urology, 33 (8) pp. 1165-1171. Peer-reviewed.
 
Novel biomarkers to predict response and prognosis in localized bladder cancer.
Lucca I., de Martino M., Klatte T., Shariat S.F., 2015. Urologic Clinics of North America, 42 (2) pp. 225-33, ix. Peer-reviewed.
 
Outcomes of minimally invasive simple prostatectomy for benign prostatic hyperplasia: a systematic review and meta-analysis.
Lucca I., Shariat S.F., Hofbauer S.L., Klatte T., 2015. World Journal of Urology, 33 (4) pp. 563-570. Peer-reviewed.
 
The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma.
Hofbauer S.L., Pantuck A.J., de Martino M., Lucca I., Haitel A., Shariat S.F., Belldegrun A.S., Klatte T., 2015. Urologic Oncology, 33 (2) pp. 68.e1-68.e7. Peer-reviewed.
 
The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study.
Lucca I., Kassouf W., Kapoor A., Fairey A., Rendon R.A., Izawa J.I., Black P.C., Fajkovic H., Seitz C., Remzi M. et al., 2015. BJU International, 116 (1) pp. 72-78. Peer-reviewed.
 
The T309G Murine Double Minute 2 Gene Polymorphism Is an Independent Prognostic Factor for Patients with Renal Cell Carcinoma.
de Martino M., Taus C., Wessely I.S., Lucca I., Hofbauer S.L., Haitel A., Shariat S.F., Klatte T., 2015. Dna and Cell Biology, 34 (2) pp. 107-112. Peer-reviewed.
 
Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?
Mathieu R., Lucca I., Klatte T., Babjuk M., Shariat S.F., 2015. Current Opinion In Urology, 25 (5) pp. 476-482. Peer-reviewed.
Upper urinary tract disease: what we know today and unmet needs
Mathieu , Bensalah , Lucca , Mbeutcha , Rouprêt , Shariat , 2015. Translational Andrology and Urology, 4 (3) pp. 261-272. Peer-reviewed.
 
Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model.
Lucca I., Shariat S.F., Briganti A., Lotan Y., Roehrborn C.G., Montorsi F., Remzi M., Seitz C., Fajkovic H., Klingler C. et al., 2015. Urologic Oncology, 33 (2) pp. 71.e21-71.e26. Peer-reviewed.
Associations Between Presenting Symptoms, Clinicopathological Parameters, and Prognosis in a Contemporary Series of Patients With Renal Cell Carcinoma
Hofbauer S.L., de Martino M., Seemann C., Zamani N., Lucca I., Haitel A., Shariat S.F., Klatte T., 2014. Korean Journal of Urology, 55 (8) pp. 505-510. Peer-reviewed.
 
Comorbidity and nutritional indices as predictors of morbidity after transurethral procedures: A prospective cohort study.
Valerio M., Cerantola Y., Fritschi U., Hubner M., Iglesias K., Legris A.S., Lucca I., Vlamopoulos Y., Vaucher L., Jichlinski P., 2014. Canadian Urological Association Journal, 8 (9-10) pp. E600-E604. Peer-reviewed.
Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.
Hofbauer S.L., Stangl K.I., de Martino M., Lucca I., Haitel A., Shariat S.F., Klatte T., 2014. British Journal of Cancer, 111 (8) pp. 1526-1531. Peer-reviewed.
 
Sex steroids and gender differences in nonmuscle invasive bladder cancer.
Lucca I., Fajkovic H., Klatte T., 2014. Current Opinion In Urology, 24 (5) pp. 500-505. Peer-reviewed.
 
Words of wisdom. Re: radical prostatectomy or watchful waiting in early prostate cancer.
Lucca I., Klatte T., Shariat S.F., 2014. European Urology, 66 (2) pp. 386-387. Peer-reviewed.
 
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.
Gontero P., Oderda M., Mehnert A., Gurioli A., Marson F., Lucca I., Rink M., Schmid M., Kluth L.A., Pappagallo G. et al., 2013/09. The Journal of urology, 190 (3) pp. 857-862. Peer-reviewed.
 
Troubles sexuels masculins et obésité [Male sexual dysfunction and obesity].
Lucca I., Paduch D.A., Pralong F., Vaucher L., 2012. Revue Médicale Suisse, 8 (365) pp. 2327-2330.
 
Fatal haematuria in a patient with an orthotopic neobladder and chronic liver failure.
Oderda M., Mondino P., Lucca I., Fiorito C., Gillo A., Zitella A., Greco A., Tizzani A., Gontero P., 2009. Urologia internationalis, 83 (3) pp. 368-369. Peer-reviewed.
 
Iliac artery-ureteral fistula: a fatal hemorrhage in a man with ureterocutaneostomy.
Morelli B., Berta G., Cattaneo E., Lucca I., Fiorito C., Oderda M., Mondino P., Valentino F., 2009. Urologia, 76 (1) pp. 53-55. Peer-reviewed.
 
New drugs currently available in non-muscle invasive bladder cancer: update on gemcitabine studies.
Gontero P., Fiorito C., Lucca I., Valentino F., Tizzani A., 2008/12. Archivio italiano di urologia, andrologia, 80 (4) pp. 162-166. Peer-reviewed.
 
[Neuroendocrine bladder cancer: oncological emergency?].
Fiorito C., Lucca I., Oderda M., Mondino P., Berta G., Cattaneo E.A., Valentino F., Zitella A., Pacchioni D., 2008. Urologia, 75 (1) pp. 57-61. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University